Abstract
The goal of this review is to look at the role of endothelial damage and dysfunction in the initiation and development of early complications that appear after hematopoietic cell transplantation (HCT). These early complications share overlapping clinical manifestations and the suspicion of underlying endothelial damage. Several studies using different approaches, such as animal and in vitro models, the analysis of soluble biomarkers and clinical findings have provided evidence of this endothelial dysfunction. Historically, the first complication in which the role of endothelial damage was elucidated was the veno-oclusive disease/sinusoidal obstructive syndrome. In the last two decades, increasing evidence of the implication of the endothelium in the pathophysiology of other syndromes such as capillary leak syndrome, transplant-associated microangiopathy, or even graft versus host disease has accumulated. This knowledge opens up potential pharmacologic interventions to prevent/and/or treat endothelial damage and, therefore, to improve the outcome of patients receiving HCT.
Article PDF
Avoid common mistakes on your manuscript.
References
Ljungman, P, Bregni, M, Brune, M, et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant 2010;45(2);219–34.
Aird, WC. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 2007;100(2);158–73.
Aird, WC. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res 2007;100(2);174–90.
Augustin, HG, Kozian, DH, Johnson, RC. Differentiation of endothelial cells: analysis of the constitutive and activated endothelial cell phenotypes. BioEssays 1994;16(12);901–6.
Cines, DB, Pollak, ES, Buck, CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998;91(10);3527–61.
Hanzu, FA, Palomo, M, Kalko, SG, et al. Translational evidence of endothelial damage in obese individuals: inflammatory and prothrombotic responses. J Thromb Haemost 2011;9(6);1236–45.
Serradell, M, Dı, M, Cases, A, et al. Uraemic medium accelerates proliferation but does not induce apoptosis of endothelial cells in culture. Haematologica 2003;18(6);1079–85.
Serradell, M, Díaz-Ricart, M, Cases, A, et al. Uremic medium causes expression, redistribution and shedding of adhesion molecules in cultured endothelial cells. Haematologica 2002;87(10);1053–61.
Carbó, C, Arderiu, G, Escolar, G, et al. Differential expression of proteins from cultured endothelial cells exposed to uremic versus normal serum. Am J Kidney Dis 2008;51(4);603–12.
Caballo, C, Palomo, M, Cases, A, et al. NFκB in the development of endothelial activation and damage in uremia: an in vitro approach. PLoS One 2012;7(8);e43374.
Aird, WC. Review article The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Sepsis 2003;101(10);3765–77.
Favero, G, Paganelli, C, Buffoli, B, Fabrizio Rodella, L, Rezzani, R. Endothelium and its alterations in cardiovascular diseases: life style intervention. Biomed Res Int 2014;2014;801896.
Richard, S, Seigneur, M, Blann, A, et al. Vascular endothelial lesion in patients undergoing bone marrow transplantation. Bone Marrow Transplant 1996;18(5);955–9.
Fusté, B, Mazzara, R, Escolar, G, Merino, A, Ordinas, A, Díaz-Ricart, M. GSF increases expression of adhesion receptors on endothelial cells through activation of p38MAPK. Haemato-logica 2004;89(5);578–85.
Mercanoglu, F, Turkmen, A, Kocaman, O, et al. Endothelial dysfunction in renal transplant patients is closely related to serum cyclosporine levels. Transplant Proc 2004;36(5);1357–60.
Bouvier, N, Flinois, JP, Gilleron, J, et al. Cyclosporine triggers endoplasmic reticulum stress in endothelial cells: a role for endothelial phenotypic changes and death. Am J Physiol Ren Physiol 2009;296(1);F160–F9.
Carmona, A, Díaz-Ricart, M, Palomo, M, et al. Distinct deleterious effects of cyclosporine and tacrolimus and combined tacrolimus-sirolimus on endothelial cells: protective effect of defibrotide. Biol Blood Marrow Transplant 2013;19(10); 1439–45.
Eissner, G, Kohlhuber, F, Grell, M, et al. Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. Blood 1995;86(11);4184–93.
Eissner, G. Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide. Blood 2002;100(1);334–40.
Hulka, BS, Wilcosky, T. Biological markers in epidemiologic research. Arch Environ Heal An Int J 1988;43(2);83–9.
Cassol, E, Misra, V, Morgello, S, Gabuzda, D. Applications and limitations of inflammatory biomarkers for studies on neurocognitive impairment in HIV infection. J Neuroimmune Pharmacol. 2013;8(5):1087–97.
Akil, A, Zhang, Q, Mumaw, CL, et al. Biomarkers for diagnosis and prognosis of sinusoidal obstruction syndrome after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2015;21(10);1739–45.
Luft, T, Benner, A, Jodele, S, et al. EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis. Lancet Haematol 2017;4(9);e414–e23.
Schroeder, MA, DiPersio, JF. Mouse models of graft-versus-host disease: advances and limitations. Dis Model Mech 2011;4(3);318–33.
Mestas, J, Hughes, CCW. Of mice and not men: differences between mouse and human immunology. J Immunol 2004;172(5);2731–8.
Srivastava, A, Ahmed Toor, A, Moll, G, et al. The role of animal models in the study of hematopoietic stem cell transplantation and GvHD: a historical overview. Front Immunol 2016;7;333.
Simonsen, M. The impact on the developing embryo and newborn animal of adult homologous cells. Acta Pathol Microbiol Scand 1957;40(6);480–500.
Billingham, RE. Studies on the reaction of injected homologous lymphoid tissue cells against the host. Ann N Y Acad Sci 1958;73(3);782–8.
Epstein, RB, Storb, R, Ragde, H, Thomas, Cytotoxic typing antisera for marrow grafting in littermate dogs. Transplantation 1968;6(1);45–58.
Storb, R, Rudolph, RH, Kolb, HJ, et al. Marrow grafts between DL-A-matched canine littermates. Transplantation 1973;15(1);92–100.
Riesner, K, Shi, Y, Jacobi, A, et al. Initiation of acute graft-versus-host disease by angiogenesis. Blood 2017;129(14);2021–32.
Penack, O, Socié, G, van den Brink, MRM. The importance of neovascularization and its inhibition for allogeneic hematopoietic stem cell transplantation. Blood 2011;117(16);4181–9.
Leonhardt, F, Grundmann, S, Behe, M, et al. Inflammatory neovascularization during graft-versus-host disease is regulated by v integrin and miR-100. Blood 2013;121(17);3307–18.
Markey, KA, MacDonald, KPA, Hill, GR. The biology of graft-versus-host disease: experimental systems instructing clinical practice. Blood 2014;124(3);354–62.
Hatoum, OA, Otterson, MF, Kopelman, D, et al. Radiation induces endothelial dysfunction in murine intestinal arterioles via enhanced production of reactive oxygen species. Arterioscler Thromb Vasc Biol. 2006;26(2):287–94.
Venkatesulu, BP, Mahadevan, LS, Aliru, ML, et al. Radiationinduced endothelial vascular injury: a review of possible mechanisms. JACC Basic Transl Sci 2018;3(4);563–72.
Spitzer, TR. Engraftment syndrome: double-edged sword of hematopoietic cell transplants. Bone Marrow Transplant 2015;50(4);469–75.
Salat, C, Holler, E, Kolb, HJ, et al. Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease. Bone Marrow Transplant 1997;19(9);909–14.
Ganster, A, Brucker, I, Holler, E, et al. In vitro monitoring of endothelial complications following hematopoietic allogeneic stem cell transplantation. Bone Marrow Transplant 2004;33(3);355–7.
Palomo, M, Diaz-Ricart, M, Carbo, C, et al. Endothelial dysfunction after hematopoietic stem cell transplantation: role of the conditioning regimen and the type of transplantation. Biol Blood Marrow Transplant 2010;16(7);985–93.
Matsuda, Y, Hara, J, Osugi, Y, et al. Post-transplant complications serum levels of soluble adhesion molecules in stem cell transplantation-related complications. Bone Marrow Transplant 2001;27;977–82.
Erdbruegger, U, Dhaygude, A, Haubitz, M, Woywodt, A. Circulating endothelial cells: markers and mediators of vascular damage. Curr Stem Cell Res Ther 2010;5(4);294–302.
Dignat-George, F, Sampol, J. Circulating endothelial cells in vascular disorders: new insights into an old concept. Eur J Haematol 2000;65(4);215–20.
Catani, L, Gugliotta, L, Vianelli, N, et al. Endothelium and bone marrow transplantation. Bone Marrow Transplant 1996;17(2);277–80.
Nürnberger, W, Michelmann, I, Burdach, S, Göbel, U. Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications. Ann Hematol 1998;76(2);61–5.
Xie, Z, Ghosh, CC, Patel, R, et al. Vascular endothelial hyper-permeability induces the clinical symptoms of Clarkson disease (the systemic capillary leak syndrome). Blood 2012;119(18); 4321–32.
Mir, E, Palomo, M, Rovira, M, et al. Endothelial damage is aggravated in acute GvHD and could predict its development. Bone Marrow Transplant 2017;52(9);1317–25.
Major-Monfried, H, Renteria, AS, Pawarode, A, et al. MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD. Blood 2018;131(25);2846–55.
Almici, C, Skert, C, Bruno, B, et al. Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 2017;52(12);1637–42.
Mohty, M, Malard, F, Abecassis, M, et al. Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 2015;50(6):781–9.
DeLeve, L, Wang, X, Kanel, GC, et al. Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome. Hepatology 2003;38(4);900–8.
DeLeve, LD, Wang, X, Guo, Y. Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence. Hepatology 2008;48(3);920–30.
DeLeve, LD. Liver sinusoidal endothelial cells in hepatic fibrosis. Hepatology 2015;61(5);1740–6.
Corbacioglu, S, Greil, J, Peters, C, et al. Defibrotide in the treatment of children with Veno-Occlusive Disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transplant 2004;33(2);189–95.
Clarkson, B, Thompson, D, Horwith, M, Luckey, EH. Cyclical edema and shock due to increased capillary permeability. Am J Med 1960;29;193–216.
Deeren, DH, Zachee, P, Malbrain, MLNG. Granulocyte colonystimulating factor-induced capillary leak syndrome confirmed by extravascular lung water measurements. Ann Hematol 2005;84(2);89–94.
Takatsuka, H, Wakae, T, Mori, A, et al. Effects of total body irradiation on the vascular endothelium. Clin Transplant 2002;16(5);374–7.
Lucchini, G, Willasch, AM, Daniel, J, et al. Epidemiology, risk factors, and prognosis of capillary leak syndrome in pediatric recipients of stem cell transplants: a retrospective single-center cohort study. Pediatr Transplant 2016;20(8);1132–6.
Dhir, V, Arya, V, Malav, IC, et al. Idiopathic Systemic Capillary Leak Syndrome (SCLS): case report and systematic review of cases reported in the last 16 years. Intern Med 2007;46(12);899–904.
Choi, CM, Schmaier, AH, Snell, MR, Lazarus, HM. Thrombotic microangiopathy in haematopoietic stem cell transplantation. Drugs 2009;69(2);183–98.
Kersting, S, Koomans, HA, Hené, RJ, Verdonck, LF. Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survival. Bone Marrow Transplant 2007;39(6);359–65.
George, JN, Selby, GB. Thrombotic microangiopathy after allogeneic bone marrow transplantation: a pathologic abnormality associated with diverse clinical syndromes. Bone Marrow Transplant 2004;33(11);1073–4.
Laskin, BL, Goebel, J, Davies, SM, Jodele, S. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood 2011;118(6);1452–62.
Walport, MJ. Complement. First of two parts. N Engl J Med 2001;344(14);1058–66.
Walport, MJ. Complement. Second of two parts. N Engl J Med 2001;344(15);1140–4.
Varela, JC, Tomlinson, S. Complement: an overview for the clinician. Hematol Oncol Clin North Am 2015;29(3);409–27.
Jodele, S, Fukuda, T, Vinks, A, et al. Eculizumab therapy in children with severe hematopoietic stem cell transplantationthrombotic microangiopathy. Biol Blood Marrow Transplant 2014;20(4);518–25.
Uderzo, C, Fumagalli, M, De Lorenzo, P, et al. Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation. Bone Marrow Transplant 2000;26(9);1005–9.
Corti, P, Uderzo, C, Tagliabue, A, et al. Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation. Bone Marrow Transplant 2002;29(6);542–3.
Jodele, S, Laskin, BL, Dandoy, CE, et al. A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury. Blood Rev. 2015;29(3):191–204.
Pidala, J. Graft-vs-host disease following allogeneic hematopoietic cell transplantation. Cancer Control 2011;18(4);268–76.
Barton-Burke, M, Dwinell, DM, Kafkas, L, et al. Graft-versus-host disease: a complex long-term side effect of hematopoietic stem cell transplant. Oncology (Williston Park) 2008;22(11 Suppl Nurse ed.);31–45.
Biedermann, BC. Vascular endothelium and graft-versus-host disease. Best Pract Res Clin Haematol 2008;21(2);129–38.
Tichelli, A, Gratwohl, A. Vascular endothelium as ‘novel’ target of graft-versus-host disease. Best Pract Res Clin Haematol 2008;21(2);139–48.
Carreras, E, Diaz-Ricart, M. The role of the endothelium in the short-term complications of hematopoietic SCT. Bone Marrow Transplant 2011;46(12);1495–502.
Riesner, K, Kalupa, M, Shi, Y, Elezkurtaj, S, Penack, O. A preclinical acute GVHD mouse model based on chemotherapy conditioning and MHC-matched transplantation. Bone Marrow Transplant 2016;51(3);410–7.
Almici, C, Skert, C, Verardi, R, et al. Changes in circulating endothelial cells count could become a valuable tool in the diagnostic definition of acute graft-versus-host disease. Transplantation 2014;98(7);706–12.
Corbacioglu, S, Cesaro, S, Faraci, M, et al. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial. Lancet 2012;379(9823);1301–9.
Richardson, PG, Soiffer, RJ, Antin, JH, et al. Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial. Biol Blood Marrow Transplant 2010;16(7);1005–17.
Richardson, PG, Carreras, E, Iacobelli, M, et al. The use of defibrotide in blood and marrow transplantation. Blood Adv. 2018;2(15):1495–509.
Tekgündüz, E, Kaya, AH, Bozdağ, SC, et al. Does defibrotide prophylaxis decrease the risk of acute graft host disease following allogeneic hematopoietic cell transplantation? Transfus Apher Sci 2016;54(1);30–4.
Author information
Authors and Affiliations
Corresponding author
Additional information
Peer review is under the responsibility of IACH
Rights and permissions
This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).
About this article
Cite this article
Palomo, M., Diaz-Ricart, M. & Carreras, E. Endothelial Dysfunction in Hematopoietic Cell Transplantation. Clin Hematol Int 1, 45–51 (2019). https://doi.org/10.2991/chi.d.190317.001
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2991/chi.d.190317.001